Report Code: A02598 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Combined hormonal contraceptives are used to prevent pregnancies. They are also used in the treatment of acne vulgaris, endometriosis, polycystic ovarian syndrome, and irregular menstrual flow by blocking ovulation. These products are widely used by women of aged between 15 and 49 years.
The factors driving the combined hormonal contraceptives market include increase in adoption of combined hormonal contraceptives products or birth control methods in the developing countries and incidence of polycystic ovary syndrome (PCOS). Moreover, rise in population attaining higher education, need of family planning, and growth in measures to prevent unwanted pregnancy further fuels the market growth. However, health risks associated with the use of contraceptives and lack of social acceptance by people restrict the market. The growth in awareness about contraceptives among people and initiatives taken by government in untapped emerging economies provide significant opportunities for market growth.
Combined hormonal contraceptives market is segmented on the basis of product type, age group, end users, and region. Based on product type, the market is bifurcated into drugs (combined oral contraceptive pills, combined injectable birth control, and combined emergency contraceptive pills) and devices (combined vaginal rings, and combined transdermal patches). On the basis of age group the market is categorized into 1524, 2534, 3544, and above 44 years. By end user, the market is classified into hospitals, household, and clinics. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key players profiled in the report include Actavis Plc., Agile Therapeutics, Inc., Allergan Plc., Bayer AG, Teva Pharmaceutical Industries Ltd., ANI Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., Noven Pharmaceuticals, Inc., Johnson & Johnson, and Mylan Inc.
Key Benefits
Combined Hormonal Contraceptives Market Report Highlights
Aspects | Details |
---|---|
By Product |
|
By Age Group |
|
By End User |
|
By Region |
|
Key Market Players | Noven Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Agile Therapeutics, Inc., Bayer AG, Mylan Inc., Johnson & Johnson, Allergan Plc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., Actavis Plc., ANI Pharmaceuticals, Inc. |
Loading Table Of Content...
Start reading.
This Report and over 71,233+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers